Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 84251-84300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05423418
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults
PHASE1
Recruiting
60 participants
Started: Aug 29, 2022 · Completed: Oct 23, 2028
2 conditions
4 sponsors
1 location
NCT05529342
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T
N/A
Enrolling by invitation
7 participants
Started: Aug 29, 2022 · Completed: Sep 29, 2038
1 condition
1 sponsor
2 locations
NCT05470699
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
NA
Active, not recruiting
30 participants
Started: Aug 29, 2022 · Completed: Apr 13, 2026
1 condition
2 sponsors
1 location
NCT05222815
Glucose Monitoring Comparison in Primary Care
NA
Active, not recruiting
360 participants
Started: Aug 29, 2022 · Completed: Oct 1, 2026
1 condition
2 sponsors
1 location
NCT05523375
Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology
NA
Active, not recruiting
352 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2026
3 conditions
4 sponsors
1 location
NCT05591937
S.T.A.N.D. Alacrity Center Signature Project
NA
Recruiting
1,000 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
2 conditions
1 sponsor
1 location
NCT05513417
Digital Care Programs for Female Pelvic Health
N/A
Enrolling by invitation
50,000 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2032
5 conditions
1 sponsor
1 location
NCT06044506
Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
PHASE1
Recruiting
3 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05339386
Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
N/A
Active, not recruiting
10 participants
Started: Aug 29, 2022 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT05626400
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
NA
Recruiting
100 participants
Started: Aug 29, 2022 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT05019664
Affixus Natural Nail System Humeral Nail PMCF
NA
Recruiting
100 participants
Started: Aug 29, 2022 · Completed: Aug 31, 2027
2 conditions
1 sponsor
4 locations
NCT05334927
China HeadAche DIsorders RegiStry
N/A
Not yet recruiting
10,000 participants
Started: Aug 29, 2022 · Completed: Dec 31, 2032
6 conditions
1 sponsor
0 locations
NCT05536609
Cast Or ePineural Suture for Digital Nerve Injuries - a Randomised Controlled Study
NA
Recruiting
166 participants
Started: Aug 29, 2022 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT05333458
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
PHASE2
Recruiting
27 participants
Started: Aug 29, 2022 · Completed: May 1, 2027
5 conditions
1 sponsor
13 locations
NCT05548296
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
PHASE2
Recruiting
353 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
1 condition
2 sponsors
69 locations
NCT05443087
TARGETed Therapy Drug MONITOring in DIGestive Oncology
NA
Recruiting
330 participants
Started: Aug 29, 2022 · Completed: Jun 30, 2027
5 conditions
1 sponsor
29 locations
NCT05222529
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
PHASE2
Recruiting
42 participants
Started: Aug 29, 2022 · Completed: Aug 30, 2027
1 condition
1 sponsor
23 locations
NCT05422521
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
NA
Recruiting
20 participants
Started: Aug 29, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06674369
Ongoing Effect of Expansion Prisms Following the Discontinuation of Use on Visual Field Enlargement and Retrograde Ganglion Cell Degeneration in Homonymous Hemianopia Patients
N/A
Active, not recruiting
15 participants
Started: Aug 28, 2022 · Completed: Oct 30, 2024
1 condition
2 sponsors
1 location
NCT05669911
Development of a Self-collection Device for Cervical Cancer Screening
NA
Active, not recruiting
235 participants
Started: Aug 28, 2022 · Completed: Dec 31, 2023
3 conditions
1 sponsor
6 locations
NCT05355831
Patient-tailored Transcranial Direct Current Stimulation to Improve Stroke Rehabilitation
NA
Recruiting
22 participants
Started: Aug 28, 2022 · Completed: Dec 31, 2024
2 conditions
5 sponsors
3 locations
NCT06698055
Muscle Adaptations in Children and Adults Following Twelve Weeks of Flywheel or Weight Stack Resistance Exercise
NA
Recruiting
96 participants
Started: Aug 28, 2022 · Completed: Feb 9, 2025
7 conditions
7 sponsors
1 location
NCT04638582
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)
PHASE2
Recruiting
44 participants
Started: Aug 28, 2022 · Completed: Dec 27, 2025
1 condition
1 sponsor
1 location
NCT06192030
Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer
N/A
Recruiting
200 participants
Started: Aug 27, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05528744
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
N/A
Recruiting
60 participants
Started: Aug 27, 2022 · Completed: Dec 1, 2026
4 conditions
1 sponsor
1 location
NCT05600738
Network Effects of Therapeutic Deep Brain Stimulation
NA
Recruiting
25 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06488001
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
PHASE2
Recruiting
132 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05196698
Home High Flow Oxygen to Reduce Acute Exacerbation of COPD
NA
Recruiting
406 participants
Started: Aug 26, 2022 · Completed: Aug 26, 2026
1 condition
1 sponsor
1 location
NCT05500222
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
PHASE3
Active, not recruiting
700 participants
Started: Aug 26, 2022 · Completed: Jan 31, 2027
2 conditions
1 sponsor
55 locations
NCT05523947
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
PHASE1/PHASE2
Recruiting
137 participants
Started: Aug 26, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
18 locations
NCT05403385
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
36 participants
Started: Aug 26, 2022 · Completed: Oct 31, 2025
2 conditions
2 sponsors
21 locations
NCT06332716
Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors
PHASE3
Recruiting
68 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05019885
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
PHASE2
Recruiting
8 participants
Started: Aug 26, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT05494658
Impact of Preoperative Oral Branched-chain Amino Acids on Reducing Postoperative Insulin Resistance.
NA
Recruiting
224 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2024
2 conditions
3 sponsors
1 location
NCT05428631
Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment
NA
Recruiting
10 participants
Started: Aug 26, 2022 · Completed: Aug 26, 2027
2 conditions
2 sponsors
2 locations
NCT05411120
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults
NA
Recruiting
1,000 participants
Started: Aug 26, 2022 · Completed: Apr 1, 2027
1 condition
1 sponsor
1 location
NCT06312826
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
NA
Active, not recruiting
806 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT05504707
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
PHASE1
Recruiting
30 participants
Started: Aug 26, 2022 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT05224661
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
N/A
Active, not recruiting
303 participants
Started: Aug 26, 2022 · Completed: Jul 1, 2029
1 condition
2 sponsors
18 locations
NCT05455619
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
PHASE1/PHASE2
Recruiting
52 participants
Started: Aug 26, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
10 locations
NCT05382637
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
PHASE2
Active, not recruiting
1 participants
Started: Aug 26, 2022 · Completed: Sep 1, 2028
1 condition
1 sponsor
1 location
NCT05518045
Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
PHASE1/PHASE2
Active, not recruiting
392 participants
Started: Aug 26, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05147103
Investigation of the Duration of Low-intensity Focused Ultrasound
NA
Enrolling by invitation
80 participants
Started: Aug 26, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05271292
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
PHASE1/PHASE2
Recruiting
36 participants
Started: Aug 26, 2022 · Completed: May 31, 2025
2 conditions
1 sponsor
11 locations
NCT05552781
H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC
PHASE1/PHASE2
Recruiting
76 participants
Started: Aug 26, 2022 · Completed: Feb 28, 2025
1 condition
2 sponsors
8 locations
NCT05433220
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
NA
Recruiting
5,000 participants
Started: Aug 25, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05454007
Tracking Post-stroke Walking Improvements From the Clinic Into the Home
NA
Recruiting
25 participants
Started: Aug 25, 2022 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT05498584
Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study
N/A
Recruiting
130 participants
Started: Aug 25, 2022 · Completed: Aug 30, 2026
1 condition
1 sponsor
1 location
NCT05793853
Hypoparathyroidism Natural History
N/A
Recruiting
94 participants
Started: Aug 25, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05370469
Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies
NA
Active, not recruiting
30 participants
Started: Aug 25, 2022 · Completed: Aug 31, 2025
9 conditions
1 sponsor
1 location
Previous
1
More pages
1683
1684
1685
1686
1687
1688
1689
More pages
2369
Next